Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03383081 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 4, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jun 30, 2025 to Jun 30, 2026
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    v11
  2. Primary completion date: Dec 31, 2024 to Jun 30, 2025
    • Study completion date: Jun 30, 2025 to Dec 31, 2025
    v10
  3. Primary completion date: Dec 2023 to Dec 31, 2024
    • Study completion date: Jun 2024 to Jun 30, 2025
    v9
  4. Primary completion date: Dec 2022 to Dec 2023
    • Study completion date: Jun 2023 to Jun 2024
    v8
  5. Primary completion date: Jun 2022 to Dec 2022
    • Study completion date: Dec 2022 to Jun 2023
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Site contact updatedv6
  2. Re-verified, no change to tracked fieldsv5
  3. Primary completion date: Jun 2021 to Jun 2022
    • Study completion date: Dec 2021 to Dec 2022
    • Start date changed from estimate of Oct 2020 to Oct 1, 2018
    v4
  4. Trial status: Not Yet Recruiting to Recruitingv3 Show 5 more changesShow less
    • Primary completion date: Dec 2019 to Jun 2021
    • Start date: Feb 2019 to Oct 2020
    • Study completion date: Jan 2020 to Dec 2021
    • Site details revised
    • Study title shortened, about 2 words
  5. Primary completion date: Jan 2019 to Dec 2019
    • Start date: Jan 2018 to Feb 2019
    • Study sites: 0 to 1
    • Study title revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is verify the efficacy and safety of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Osteoarthritis, and in addition, provide basis for exploring the treatment regimen of UC-MSC therapy in different degree of cartilage defect disease
Trial Details
NCT Number NCT03383081
Lead Sponsor Sclnow Biotechnology Co., Ltd.
Conditions
(from sponsor)		 Osteoarthritis, Knee
Related terms Osteoarthritis, Osteoarthritis, Knee
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov